RAPT Therapeutics OverviewRAPT Therapeutics EBIT
EBIT (Earnings Before Interest and Taxes) analysis for RAPT.
Quarterly EBIT
-$19.37M
↑ 2.11% YoY
As of Sep 30, 2025
Annual EBIT (TTM)
-$110.74M
↑ 3.58% YoY
Trailing 12 months ending Sep 30, 2025
RAPT Therapeutics OverviewEBIT (Earnings Before Interest and Taxes) analysis for RAPT.
As of Sep 30, 2025
Trailing 12 months ending Sep 30, 2025